M.J. Welsh and A.E. Smith, RAC Application 
Ad2-ORF6/PGK-CFTR 
Item 5 - Clinical Protocol 
30. Lewiston, N., V. King, D. Umetsu, V. Starnes, S. Marshall, M. Kramer and J. Theodore. 1991. 
Cystic Fibrosis patients who have undergone heart-lung transplantation benefit from maxillary sinus 
antrostomy and repeated sinus lavage. Transplant. Proc 23:1207-1208. 
31. Umetsu, D.T., R.B. Moss, V.V. King and N.J. Lewiston. 1990. Sinus disease in patients with severe 
cystic fibrosis: relation to pulmonary exacerbation. Lancet 335:1077-1078. 
32. Yamaya, M., W.E. Finkbeiner, S.Y. Chun and J.H. Widdicombe. 1992. Differentiated structure and 
function of cultures from human tracheal epithelium. Am J Physiol 262:L7 13-L724. 
33. Van-Scott, M.R., J.R. Yankaskas and R.C. Boucher. 1986. Culture of airway epithelial cells: research 
techniques. Exp Lung Res 11:75-94. 
34. Wu, R., J. Yankaskas, E. Cheng, M.R. Knowles and R. Boucher. 1985. Growth and differentiation 
of human nasal epithelial cells in culture. Serum-free, hormone-supplemented medium and proteoglycan 
synthesis. Am Rev Respir Dis 132:311-320. 
35. Jetten, A.M. 1991. Growth and differentiation factors in tracheobronchial epithelium. Am J Physiol 
260:L361-L373. 
36. Ginsberg, H.S., W. Lundholm-Beacham, R.L. Horstwood, B. Pemis, W.S.M. Wold, R.M. Chanock 
and G.A. Prince. 1989. Role of early region E (E3) in pathogenesis of adenovirus disease. Proc Natl 
Acad Sci 86:3823-3827. 
37. Shasby, D.M., M. Winter and S.S. Shasby. 1988. Oxidants and conductance of cultured epithelial cell 
monolayers: inositol phospholipid hydrolysis. Am J Physiol 255:C781-C788. 
38. Harkema, J.R., C.G. Plopper, D.M. Hyde, D.W. Wilson, J.A. St.George and V.J. Wong. 1987. 
Nonolfactory surface epithelium of the nasal cavity of the bonnet monkey: A morphologic and 
morphometric study of the transitional and respiratory epithelium. Am J Anat 180:266-279. 
39. Taussig, L.M., J. Kattwinkel, W.T. Friedewald and P.A. di Sant'Agnese. 1971. A new prognostic 
score and clinical evaluation system for cystic fibrosis. Journal of Pediatrics 82:380-390. 
40. Ginsberg, H.S. 1984. The Adenoviruses, Plenum Press, New York: 
41. Alton, E.W.F.W., J.G. Hay, C. Munro and D.M. Geddes. 1987. Measurement of nasal potential 
difference in adult cystic fibrosis, Young's syndrome, and bronchiectasis. Thorax 42:815-817. 
42. Hajek, M., J.D. Heitger and F.K. Hansel. 1926. Nasal Accessory Sinuses, CV Mosby, pp. 211-212. 
43. Wilson, W.R. and W.W. Montgomery. 1991. Infectious Disease of the Paranasal Sinuses. In: Otol- 
aryngology, Paparella, Shumrick, Gluckman and Meyerhoff. eds WB Saunders, Philadelphia: p. 1843- 
1860. 
44. Wilmott, R.W., J.T. Kassab, P.L. Kilian, W.R. Benjamin, S.D. Douglas and R.E. Wood. 1990. 
Increased levels of interleukin- 1 in bronchoalveolar washings from children with bacterial pulmonary 
infections. Am Rev Respir Dis 142:365-368. 
45. Greally, P., M.J. Hussein, a.P. Sampson, D. Vergani, P.J. Piper and J.F. Price. 1993. Sputum 
tumor necrosis factor-alpha and leukotriene concentrations correlate with airflow obstruction in children 
with cystic fibrosis. Arch Dis Child 68:389-392. (Abstract). 
46. McElvaney, N.G., H. Nakamura, P. Birrer, C.A. Hebert, W.L. Wong, M. Alphonso, J.B. Baker, 
M.A. Catalano and R.G. Crystal. 1992. Modulation of airway inflammation in cystic fibrosis. In vivo 
suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant 
secretory leukoprotease inhibitor. J Clin Invest 90:1296-1301. 
Recombinant DNA Research, Volume 18 
[881] 
